A 5-Star Dividend Stock to Buy With a 3.7% Yield

The stock of this narrow-moat company is undervalued by a remarkable 50%.

Seth Goldstein, CFA 25 April, 2024 | 4:37AM
Facebook Twitter LinkedIn

Basic Materials Sector artwork

FMC is a pure-play crop chemical producer and one of the five largest patented crop protection companies in the world. Its largest products—the diamides, which generated 39% of sales in 2023—are set to see patents expire and face increased competition from generic products in the coming years. However, a pipeline of new premium products should allow FMC to continue producing new crop chemicals as older products roll off patent. The company has a strong pipeline of synthetic and biological products that should more than replace lost diamide profits. FMC’s product portfolio currently skews toward insecticides, which generate over half of revenue, but many of its new products in the pipeline are herbicides and fungicides, which should result in a more balanced portfolio among the three primary types of crop protection chemicals as new products are commercialized over the next decade.

Key Morningstar Metrics for FMC

  • Fair Value Estimate: US$110
  • Star Rating: 5 Stars
  • Economic Moat Rating: Narrow
  • Uncertainty Rating: High

Economic Moat Rating

Our narrow economic moat rating is based on intangible assets, as FMC’s patented crop protection products provide the company with pricing power. Crop chemical companies realize premium prices on their patented products, generating returns in excess of the cost of capital. It typically takes 5-10 years to bring new products to market. In addition to years of research and development, these chemicals require regulatory approvals as they are tested for consumer, environmental, and worker safety. Approved patents have protection that lasts for 20 years from the research phase on the active ingredient, which is known as the molecule. Crop chemical companies take additional steps to extend a successful product’s patent life by up to five years by patenting the product formula and specific manufacturing processes. We expect demand for FMC’s new products will allow the company to continue to safely outearn its cost of capital over at least the next decade.

Get the Latest Stock Insights in Your Inbox

Subscribe Here

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar Rating
FMC Corp56.58 USD-1.07Rating

About Author

Seth Goldstein, CFA

Seth Goldstein, CFA  Seth Goldstein, CFA, is an equity analyst for Morningstar

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy       Disclosures        Accessibility